- Deluxe Corp (NYSE:DLX) has appointed Chip Zint as SVP and CFO, effective Oct. 17.
- Zint will succeed Scott Bomar, who is stepping down to assume a senior role at a former employer.
- Zint joined Deluxe in 2020 and serves as VP, Corporate Finance.
- Outlook: Deluxe also reaffirmed its financial outlook for FY22.
- The company sees full-year revenue growth to be 10% – 12%, excluding the impact of business exits, or 8% – 10% as reported.
- Full-year adjusted EBITDA rate is expected to be 18.5% – 19.0%.
- Price Action: DLX shares are trading lower by 3.72% at $16.58 on the last check Friday.
Alterity Therapeutics Announced Presentation of Data from the bioMUSE Natural History Study at the American Autonomic Society Annual Meeting
Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) today announced a poster presentation from the ongoing Biomarkers of Progression in Multiple System Atrophy (bioMUSE) natural history study was given at the American Autonomic Society (AAS) 2022 Annual Conference held November 2-5, 2022.
